474 related articles for article (PubMed ID: 33559726)
1. Intra-abdominal lymphatic malformation management in light of the updated International Society for the Study of Vascular Anomalies classification.
Elbaaly H; Piché N; Rypens F; Kleiber N; Lapierre C; Dubois J
Pediatr Radiol; 2021 May; 51(5):760-772. PubMed ID: 33559726
[TBL] [Abstract][Full Text] [Related]
2. A multidisciplinary approach to management of abdominal lymphatic malformations.
Zamora AK; Barry WE; Nowicki D; Ourshalimian S; Navid F; Miller JM; Zeinati C; Anselmo DM
J Pediatr Surg; 2021 Aug; 56(8):1425-1429. PubMed ID: 33526253
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonographic diagnosis, classification, and treatment of cervical lymphatic malformation in paediatric patients: a retrospective study.
Li J; Zhong W; Geng X; Liu X; Zhang X; Wang Y; Li H
BMC Pediatr; 2020 Sep; 20(1):441. PubMed ID: 32950065
[TBL] [Abstract][Full Text] [Related]
4. Bowel perforation following percutaneous sclerotherapy of an intra-abdominal lymphatic malformation.
Durand RE; Heye P; Cahill AM; Laje P; Srinivasan AS
Pediatr Radiol; 2022 Jul; 52(8):1592-1595. PubMed ID: 35445817
[TBL] [Abstract][Full Text] [Related]
5. Symptom Resolution and Volumetric Reduction of Abdominal Lymphatic Malformations With Sclerotherapy.
Madsen HJ; Annam A; Harned R; Nakano TA; Larroque LO; Kulungowski AM
J Surg Res; 2019 Jan; 233():256-261. PubMed ID: 30502256
[TBL] [Abstract][Full Text] [Related]
6. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
[TBL] [Abstract][Full Text] [Related]
7. Management of cervicofacial lymphatic malformations requires a multidisciplinary approach.
Zobel MJ; Nowicki D; Gomez G; Lee J; Howell L; Miller J; Zeinati C; Anselmo DM
J Pediatr Surg; 2021 May; 56(5):1062-1067. PubMed ID: 33982660
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
Hill RH; Shiels WE; Foster JA; Czyz CN; Stacey A; Everman KR; Cahill KV
Ophthalmic Plast Reconstr Surg; 2012; 28(2):119-25. PubMed ID: 22366666
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic malformations.
Kulungowski AM; Patel M
Semin Pediatr Surg; 2020 Oct; 29(5):150971. PubMed ID: 33069296
[TBL] [Abstract][Full Text] [Related]
10. Utilizing immediate preoperative n-BCA in the resection of head and neck venous and lymphatic malformations.
Puccia R; Staricha K; Carlberg VM; Moe D; Chun R
Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110388. PubMed ID: 33152979
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic malformations in children: treatment outcomes of sclerotherapy in a large cohort.
Bouwman FCM; Kooijman SS; Verhoeven BH; Schultze Kool LJ; van der Vleuten CJM; Botden SMBI; de Blaauw I
Eur J Pediatr; 2021 Mar; 180(3):959-966. PubMed ID: 33051716
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Markovic JN; Nag U; Shortell CK
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
[TBL] [Abstract][Full Text] [Related]
13. Vascular Anomalies (Part I): Classification and Diagnostics of Vascular Anomalies.
Sadick M; Müller-Wille R; Wildgruber M; Wohlgemuth WA
Rofo; 2018 Sep; 190(9):825-835. PubMed ID: 29874693
[TBL] [Abstract][Full Text] [Related]
14. Sclerotherapy for intra-abdominal lymphatic malformations in children.
Russell KW; Rollins MD; Feola GP; Arnold R; Barnhart DC; Scaife ER
Eur J Pediatr Surg; 2014 Aug; 24(4):317-21. PubMed ID: 23846982
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):691-4. PubMed ID: 24153336
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous sclerotherapy for head and neck lymphatic malformations in neonates and infants ≤12 months of age.
Caton MT; Duvvuri M; Baker A; Smith ER; Narsinh KH; Amans MR; Hetts SW; Higashida RT; Cooke DL; Dowd CF
J Neurointerv Surg; 2023 Dec; 15(12):1242-1246. PubMed ID: 36414388
[TBL] [Abstract][Full Text] [Related]
17. Patient radiation exposure from embolo-sclerotherapy of peripheral vascular malformations.
Giet L; Evans N; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Brookes J; Lim CS
J Vasc Surg; 2021 May; 73(5):1794-1799. PubMed ID: 33075453
[TBL] [Abstract][Full Text] [Related]
18. Vascular Anomaly Syndromes in the ISSVA Classification System: Imaging Findings and Role of Interventional Radiology in Management.
Wang MX; Kamel S; Elsayes KM; Guillerman RP; Habiba A; Heng L; Revzin M; Mellnick V; Iacobas I; Chau A
Radiographics; 2022 Oct; 42(6):1598-1620. PubMed ID: 36190850
[TBL] [Abstract][Full Text] [Related]
19. Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes.
Ghaffarpour N; Petrini B; Svensson LA; Boman K; Wester T; Claesson G
Acta Paediatr; 2015 Nov; 104(11):1169-73. PubMed ID: 26081020
[TBL] [Abstract][Full Text] [Related]
20. Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations.
Caton MT; Baker A; Smith ER; Perez E; Hemphill K; Cooke DL; Dowd CF
J Neurointerv Surg; 2023 Sep; 15(9):931. PubMed ID: 35977819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
